Navigation Links
VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
Date:6/11/2019

Veterinary Regenerative Medicine company, VetStem Biopharma, parent company of Personalized Stem Cells Inc. (PSC), has announced that their GMP facility for cell production is now approved by the California Department of Public Health, Food and Drug Branch for manufacturing. This is an important milestone for VetStem as it expands into contract cell manufacturing services. VetStem is currently contracted with multiple companies to develop and perform cell-based manufacturing (to include stem cells) for use in human clinical trials. PSC will be the first VetStem client to launch human stem cell clinical trials planned for late 2019.    

VetStem has been providing stem cell processing services for veterinarians for over 15 years and is now providing Contract Manufacturing Services to companies engaged in human clinical trials. VetStem founder and CEO, Dr. Bob Harman stated, “In order to legally manufacture human stem cell products for clinical trials, a laboratory must comply with FDA cGMP regulations and must also have a California Department of Public Health manufacturing license. This month we underwent an intensive inspection by three inspectors from the California DPH and we passed the inspection first time through. I am proud of the high standards set at VetStem by Chief Operating Officer, Dr. Carolyn Wrightson and Senior Quality Manager, Scott Caton along with their dedicated staff. We will be producing human cell therapy products for multiple companies beginning this summer.”

PSC’s first clinical trials are planned to begin in late 2019 with an initial focus on osteoarthritis and orthopedic conditions. PSC has also licensed VetStem’s extensive patent portfolio for certain technologies and stem cell applications in the United States. The inspection and approval by the California Department of Public Health is one of the final approvals needed in order to initiate patient specific stem cell manufacturing.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, FDA compliant autologous stem cells (from the patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell therapy and regenerative medicine within the FDA-IND process by providing quality manufactured, safety tested cells and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_parent_company_of_personalized_stem_cells_is_approved_for_stem_cell_manufacturing_by_the_california_department_of_public_health/prweb16369997.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Shares the Story of Atlas Who Was Successfully Treated with VetStem Cell Therapy by Dr. Colter Negranti
2. VetStem Biopharma Shares the Success Story of Frank who was Treated with VetStem Cell Therapy by Pain Management Specialist Dr. Jamie Gaynor
3. VetStem Biopharma Shares the Story of Sonny Bar Lisa Who Was Successfully Treated With VetStem Cell Therapy
4. VetStem Regenerative Cell Therapy Helps Arthritic Sun Bear at the World-Famous San Diego Zoo
5. VetStem Biopharma is Pleased to Share the Success Story of Bogey Who Was Treated with VetStem Cell Therapy by Dr. Ava DeCozio
6. VetStem Biopharma Shares the Story of San Fransisko Who Advanced in His Dressage Career After Being Treated with VetStem Cell Therapy
7. VetStem Biopharma Launches Human Stem Cell Company in San Diego
8. VetStem Biopharma is Pleased to Announce Dr. Douglas Stramel of Advanced Care Veterinary Services is Successfully Using the Pall V-PET™ Platelet Therapy System
9. VetStem Biopharma is Pleased to Share the Success Story of Rascal who was Treated with VetStem Cell Therapy by Dr. Deborah Fegan
10. Veterinarian Dr. Patrick Leadbeater Brings VetStem Regenerative Cell Therapy to the Island of Kauai
11. VetStem Biopharma Shares News of the Successful Treatment of Partially Torn Cruciate Ligament in Young Labrador Retriever with the Pall V-PET™ Platelet Therapy System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2020)... , ... January 22, 2020 , ... ... developments in the cosmetic surgery industry at two recent North American investor forums ... at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group ... Midwest Region Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing ... Darrell brings over 30 years of sales experience working across multiple different market ...
(Date:1/22/2020)... ... ... QCDx , a private biotech company that has developed a breakthrough ... sale of the proprietary RareScope™ instrument to the Carole and Ray Neag Comprehensive Cancer ... , “The RareScope can detect and isolate intact and live Circulating Tumor Cells from ...
(Date:1/10/2020)... and MALVERN, Pa. (PRWEB) , ... January 09, ... ... File (TMF) software and expert services, today announced the acquisition of Cunesoft, a ... functionality to meet the business objectives of life sciences companies. , Based in ...
Breaking Biology Technology:
(Date:1/29/2020)... ... January 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), ... has announced a record earnings year for 2019. With final numbers to be ... twenty percent increase in revenue and a thirty percent increase in gross profit, ...
(Date:1/28/2020)... Mass. (PRWEB) , ... January 28, 2020 , ... ... for life sciences companies and government agencies, announced that the firm has established ... the country. Tunnell’s Cambridge office will be in the Cambridge Innovation Center (CIC), ...
(Date:1/27/2020)... ... January 27, 2020 , ... On Thursday, February 20, 2020 at 10am ... Reed Tech and Richard Castle, Global Account Manager Medical Device at PRISYM ... topics include EU MDR timing deadlines, best practices in creating and submitting product data ...
Breaking Biology News(10 mins):